StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Neogen's price to book ratio was 1.2× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.4× to 5.7×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.2×+0.5
2025Dec 31, 20250.7×−0.1
2024Dec 31, 20240.8×−0.5
2023Dec 29, 20231.4×−0.5
2022Dec 30, 20221.9×−3.8
2021Dec 31, 20215.7×+0.1
2020Dec 31, 20205.6×+0.4
2019Dec 31, 20195.2×+0.1
2018Dec 31, 20185.1×−1.4
2017Dec 29, 20176.5×−1.5
2016Dec 30, 20168.0×+0.3
2015Dec 31, 20157.7×+0.0
2014Dec 31, 20147.7×−0.5
2013Dec 31, 20138.2×+1.9
2012Dec 31, 20126.3×+1.4
2011Dec 30, 20114.9×–

More Neogen figures

See a number that looks wrong?